| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $25.6M | — | -31.3% |
| Cost of Revenue | $22.9M | — | +34.1% |
| Gross Profit | $2.7M | — | -86.6% |
| R&D Expense | $4.5M | — | -8.3% |
| SG&A Expense | $8.3M | — | +11.6% |
| Operating Income | -$10.2M | — | -230.8% |
| Interest Expense | -$37K | — | -184.1% |
| Pre-tax Income | -$9.7M | — | -214.1% |
| Income Tax | $81K | — | -28.3% |
| Net Income | -$9.8M | — | -216.6% |
| EPS (Basic) | -$0.76 | — | -215.2% |
| EPS (Diluted) | -$0.76 | — | -216.9% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10.6M | -59.8% | +650.3% |
| Inventory | $35.4M | +14.5% | +26.7% |
| Current Assets | $77.7M | -12.2% | -18.3% |
| Total Assets | $144.6M | -5.5% | -9.6% |
| Current Liabilities | $25.6M | +4.6% | +51.4% |
| Long-term Debt | $0 | — |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$15.1M | — | -30.9% |
| Capital Expenditures | $2.5M | — | -22.5% |
| Investing Cash Flow | -$389K | — | -106.2% |
| Financing Cash Flow | -$305K | — | -54.8% |
| Free Cash Flow | -$17.6M | — | -19.3% |
| — |
| Total Liabilities | $28.7M | +4.4% | +66.8% |
| Stockholders' Equity | $115.9M | -7.7% | -18.8% |